PMID- 21432991 OWN - NLM STAT- MEDLINE DCOM- 20110701 LR - 20191210 IS - 1552-4930 (Electronic) IS - 1552-4922 (Linking) VI - 79 IP - 4 DP - 2011 Apr TI - Reevaluation of quantitative flow cytometric analysis for TLR2 on monocytes using F(ab')2 fragments of monoclonal antibodies. PG - 247-55 LID - 10.1002/cyto.a.21000 [doi] AB - In patients with refractory infections, reliable markers that monitor the severity and healing process are needed. The expression level of toll-like receptor 2 (TLR2) on monocytes is such candidate. In the conventional assay system, the whole IgG (wIgG) form of anti-TLR2 mAb has been used with control IgG, which blocks nonantigen-specific bindings. However, the competitive reactions against Fcgamma receptors (FcgammaRs) between labeled anti-TLR2 mAbs and control IgG should be considered. Our goal was to precisely quantify TLR2 expression level on monocytes by flow cytometry (FCM). In this study, we prepared anti-TLR2 mAbs, D45 (IgG2a), and D29 (IgG1), as well as their fragment antigen-binding [F(ab')(2) ] fragments to avoid nonantigen-specific binding to FcgammaRs. And then, we determined TLR2 expression levels on monocytes by using these mAbs/fragments and our calibration system using recombinant TLR2 beads. The binding of PE-labeled D45 wIgG to monocytes was completely blocked with unlabeled D45 wIgG, but not with unlabeled D45 F(ab')(2) fragment. Although the nonantigen-specific binding of D29 wIgG to nonstimulated monocytes was negligible, it was enhanced in interleukin-10-stimulated monocytes. It proved difficult to completely block nonantigen-specific binding of D45 and D29 wIgGs by treatment with control IgG. It was demonstrated that the use of fluorescent-labeled antigen-binding region lacking the fragment crystallizable portion of anti-TLR2 mAb [such as the PE-labeled F(ab')(2) fragment] is indispensible for quantification of TLR2 levels on monocytes in flow cytometry. . CI - Copyright (c) 2010 International Society for Advancement of Cytometry. FAU - Oba, Ryutaro AU - Oba R AD - Department of Advanced Medicine and Development, BML Inc., Saitama, Japan. FAU - Orihara, Koji AU - Orihara K FAU - Kumagai, Tomoaki AU - Kumagai T FAU - Hirai, Hiroyuki AU - Hirai H FAU - Nagata, Kinya AU - Nagata K FAU - Hamasaki, Shuichi AU - Hamasaki S FAU - Tei, Chuwa AU - Tei C FAU - Masataka, Nakamura AU - Masataka N LA - eng PT - Evaluation Study PT - Journal Article DEP - 20101223 PL - United States TA - Cytometry A JT - Cytometry. Part A : the journal of the International Society for Analytical Cytology JID - 101235694 RN - 0 (Antibodies, Monoclonal) RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 0 (Immunoglobulin Fab Fragments) RN - 0 (Receptors, IgG) RN - 0 (Toll-Like Receptor 2) SB - IM MH - Animals MH - Antibodies, Monoclonal/*immunology MH - Bacterial Infections/immunology MH - Biomarkers/metabolism MH - Cytokines/immunology MH - Flow Cytometry/instrumentation/*methods/standards MH - Humans MH - Immunoglobulin Fab Fragments/*immunology MH - Mice MH - Monocytes/cytology/*immunology MH - Receptors, IgG/immunology MH - Toll-Like Receptor 2/*immunology EDAT- 2011/03/25 06:00 MHDA- 2011/07/02 06:00 CRDT- 2011/03/25 06:00 PHST- 2010/07/07 00:00 [received] PHST- 2010/10/02 00:00 [revised] PHST- 2010/10/29 00:00 [accepted] PHST- 2011/03/25 06:00 [entrez] PHST- 2011/03/25 06:00 [pubmed] PHST- 2011/07/02 06:00 [medline] AID - 10.1002/cyto.a.21000 [doi] PST - ppublish SO - Cytometry A. 2011 Apr;79(4):247-55. doi: 10.1002/cyto.a.21000. Epub 2010 Dec 23.